The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

I make it my mission to shield every inch of my exposed, vulnerable, high-risk skin, including hands, forearms, chest, neck, and knees. Yeah, people mock me. But we’ll see who’s laughing when my knees ...

A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the ...

Make your antibiotic medication as effective as possible by getting these answers before you leave the doctor's office or ...

Eye health is often overlooked. Tons of Americans skip their annual eye exams: Of those who are considered to be at high risk ...

While outside this spring, it's easy to forget about a small biting inconvenience. But May is Lyme Disease Awareness Month, a ...

Medical Director for the Citizen Potawatomi Health Services Dr. Braden Parmer provides answers to some common questions related to the use of Narcan.

Recommendations from the American College of Obstetricians and Gynecologists outline a range of pain management options for ...

The approval marks the second international approval for rozanolixizumab (Rystiggo; UCB Pharma) for generalized myasthenia ...

From honey poultices to superglued cuts, explore some of the weirdest wound care hacks ever attempted – and why knowing the ...